Exhibit 23.1
|
|
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement on Form S-8 of our report dated April 12, 2024, relating to the consolidated financial statements of ASLAN Pharmaceuticals Limited, appearing in the Annual Report on Form 20-F of ASLAN Pharmaceuticals Limited for the year ended December 31, 2023.
/s/ Deloitte & Touche LLP Singapore
Deloitte & Touche LLP
Singapore
April 12, 2024
